Back to Search
KELLEY MCINTYRE, MD
MD
Internal Medicine Physician
NPI: 1497710693IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obesity Medicine (Internal Medicine) Physician
Internal Medicine — Obesity Medicine
Code: 207RB0002X
36930(KY)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
36930(KY)
Education
OTHER
Class of 1999
Research & Publications (20)
The impact of sheep breed on the risk of classical scrapie.
PMID 19678970·Epidemiol Infect·2010
7-preclinical
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
PMID 19652024·J Pharmacol Exp Ther·2009
7-preclinical
Prevalence of sheep infected with classical scrapie in Great Britain, 1993-2007.
PMID 19351431·Epidemiol Infect·2009
7-preclinical
Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium).
PMID 19085814·Planta Med·2009
7-preclinical
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
PMID 19459042·Breast Cancer Res Treat·2009
3-trial
Cognitive dysfunction after experimental febrile seizures.
PMID 19000675·Exp Neurol·2009
7-preclinical
Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase.
PMID 19376699·Bioorg Med Chem Lett·2009
7-preclinical
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
Collaborative approach in assessing community readiness for a pandemic event.
PMID 19643280·Am J Infect Control·2009
8-other
Epidemiological characteristics of classical scrapie outbreaks in 30 sheep flocks in the United Kingdom.
PMID 19098982·PLoS One·2008
7-preclinical
The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitor.
PMID 18313298·Bioorg Med Chem Lett·2008
7-preclinical
Activation of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces the behavioral consequences of social defeat.
PMID 18692968·Psychoneuroendocrinology·2008
7-preclinical
A structured light-based system for scanning subcutaneous tumors in laboratory animals.
PMID 18589868·Comp Med·2008
7-preclinical
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
PMID 18621615·Clin Breast Cancer·2008
3-trial
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors.
PMID 18359226·Bioorg Med Chem Lett·2008
8-other
Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors.
PMID 18364256·Bioorg Med Chem Lett·2008
7-preclinical
No temporal trends in the prevalence of atypical scrapie in British sheep, 2002-2006.
PMID 18384678·BMC Vet Res·2008
7-preclinical
Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.
PMID 18072718·J Med Chem·2008
7-preclinical
Core exploration in optimization of chemokine receptor CCR4 antagonists.
PMID 17098428·Bioorg Med Chem Lett·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3 AUDUBON PLAZA DR STE LL2
LOUISVILLE, KY 40217 - Phone
- (502) 636-8095
Quick Facts
- NPI
- 1497710693
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile